1. Nutraceuticals: From History to Modern Outlook 2. Implications of Polyphenols in Cancer Management 3. Revealing Novel Sources of Breast Cancer Inhibitors 4. A Promising Natural Product in Diffuse Large B-Cell Lymphoma Therapy 5. Inhibiting Inflammation via IL-17/NF-κB Pathway 6. Mechanistic Pathways and Clinical Aspects of Natural CDK Inhibitors on Cancer Progression 7. Natural Kinase Inhibitors in Lymphoma Therapy 8.

Natural Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma 9. Identification of Marine Natural Products as STAT3 Inhibitors for Efficient Anticancer Therapy 10. Multitarget Potential of Phytochemicals 11. Naturally Occurring Compounds as Potential Inhibitors of Epidermal Growth Factor Receptors 12. Exploring Potential Phytochemicals for Hepatocellular Carcinoma 13. The Natural Product in Resistant Lung Cancer 14. Anticancer Potential of Novel Natural Product Derivatives Targeting the PI3K/AKT Signaling Pathway 15. Plant-Based mTOR Inhibitors for Cancer Therapy 16.

Role of Nutraceuticals in Combating Oxidative Stress via Modulating MAPK Signalling 17. Epigenetic Effects of SCFAs: Butyrate's Effects on Spleen Tyrosine Kinase (Syk) in Tumor Progression 18. Exploring Chemopreventive Effects of Olive Products Attenuating Cancer Signaling 19. Confronting Overexpressed Tyrosine Kinases with Curcumin: Advancing Adjuvant Cancer Therapies 20. Medicinal Benefits of Polyphenols in Cancer Prevention and Therapy through Suppression of PI3K Pathway 21. Structural Biology-Based Design of Selective Protein Kinase Inhibitors 22. Identifying Novel Cyclin-Dependent Kinase Attenuators Based on High Throughput Screening 23. Exploring the Potential of Pseudosaccharine Derivatives as Anti-Proliferative Agents and Kinase Inhibitors 24.

Integrating Structure-Based Modeling and Advanced MD Simulation Strategy in Revealing the Potency of Natural Products as Dual Kinase Inhibitors 25. Discovering Novel Kinase Inhibitors: Moving from Structure to Clinical Leads.